|
Copies of this special issue of Menopause may be obtained from NAMS for a nominal fee by downloading this Order Form, or simply visit the secure NAMS
Web Store.
This 56-page collection of original review articles offers valuable information on the management of breast cancer risk in postmenopausal women. Oversight of the articles, written by distinguished experts, was provided by Guest Editor Victor G. Vogel, MD, MHS, a highly respected leader in the field. Contents were also peer-reviewed. The review offers an opportunity to earn 3.5 CME credits (in print and online) until June 30, 2009.
Articles include:
- Introduction to special issue on managing breast cancer risk in postmenopausal women
- Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer
- Randomized clinical trials of raloxifene: reducing the risk of osteoporosis and breast cancer in postmenopausal women
- Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer
- Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri-and postmenopausal women at increased breast cancer risk
- Chemoprevention in postmenopausal women
The Society hopes that you will enjoy this supplement. However, please note that this material represents the individual opinions of the contributors, not necessarily those of NAMS.
|